Skip to content
Dx

ICD-10-CM 2027 diagnosis code

D22.62Melanocytic nevi of left upper limb, including shoulder

✓ Billable / specific

D22.62 is a valid, billable ICD-10-CM code for melanocytic nevi of left upper limb, including shoulder. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.

Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About D22.62

D22.62 is the ICD-10-CM diagnosis code for Melanocytic nevi of left upper limb, including shoulder. It belongs to category D22 (Melanocytic nevi), block D10-D36 (benign neoplasms, except benign neuroendocrine tumors) and chapter 2 (neoplasms). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within D22.6 (Melanocytic nevi of upper limb, including shoulder), D22.62 is specifically for Melanocytic nevi of left upper limb, including shoulder. Related codes cover unspecified upper limb, including shoulder (D22.60) and right upper limb, including shoulder (D22.61).

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 606 (Minor Skin Disorders with MCC, relative weight 1.5728) and DRG 607 (Minor Skin Disorders without MCC, relative weight 0.8772), in MDC 09 (Diseases and Disorders of the Skin, Subcutaneous Tissue and Breast), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 216.6 (benign neoplasm of skin of upper limb, including shoulder).

Notes that apply from higher levels

Instructions written at a parent level also apply to D22.62.

› From D22 Melanocytic nevi
Includes
  • atypical nevus
  • blue hairy pigmented nevus
  • nevus NOS

Broader instructions also apply from Chapter 2: Neoplasms.

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

MDC 09 · Diseases and Disorders of the Skin, Subcutaneous Tissue and Breast

ICD-9-CM equivalent

Converter →
  • 216.6Benign neoplasm of skin of upper limb, including shoulderapproximate

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about D22.62

Is D22.62 billable?

Yes. D22.62 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can D22.62 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict D22.62 as a principal diagnosis.

Is D22.62 a CC or MCC?

No. D22.62 is neither a CC nor an MCC under MS-DRG v44.0.

What DRG does D22.62 group to?

D22.62 is used in the MS-DRG v44.0 logic for MS-DRG 606 (Minor Skin Disorders with MCC) and MS-DRG 607 (Minor Skin Disorders without MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.

What is the ICD-9 code for D22.62?

The CMS General Equivalence Mappings map D22.62 to ICD-9-CM 216.6.